Variations in Oral Microbiota Composition Are Associated With a Risk of Throat CancerOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study used next-generation 16S ribosomal RNA gene sequencing to characterize the salivary (oral) microbiota associated with throat cancer. Researchers compared microbial community diversity and composition among throat cancer patients, vocal cord polyp patients, and healthy controls. They also built a diagnostic model based on constituent bacteria and verified select findings with real-time quantitative PCR.
Who was studied?
The study analyzed 70 oral (salivary) samples collected from three groups: 32 patients with throat cancer, nine patients with a vocal cord polyp, and 29 healthy individuals serving as normal controls. All participants were drawn from a clinical setting where throat cancer and vocal cord polyp diagnoses had been made, alongside disease-free comparison subjects.
What were the most important findings?
The salivary microbiota of throat cancer patients was significantly different from that of polyp patients and healthy individuals, with beta diversity clearly divergent in the cancer group. Alpha diversity was significantly reduced in cancer patients, as shown by the Chao1 estimator (P = 8.1e-05), Simpson index (P = 0.0045), and Shannon index (P = 0.0071). The genera Aggregatibacter, Pseudomonas, Bacteroides, and Ruminiclostridium were significantly enriched in throat cancer patients compared with the other two groups, a result confirmed by qPCR. A diagnostic model built from these bacterial constituents achieved 87.5% accuracy in distinguishing cancer patients from the other groups.
What are the greatest implications of this study?
These findings suggest that reduced salivary microbial diversity and enrichment of specific bacterial genera may serve as biological indicators associated with throat cancer. The strong diagnostic accuracy of the bacteria-based model points to the potential for salivary microbiota profiling as a non-invasive tool to help distinguish throat cancer from benign vocal cord polyps and healthy states. Because this is an association-based study, further research is needed to determine whether these microbial shifts are causal, secondary to tumor presence, or influenced by other factors before clinical application.